1. Academic Validation
  2. Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells

Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells

  • Sci Rep. 2016 Apr 28;6:25272. doi: 10.1038/srep25272.
Hua-Yu Zhu 1 Wen-Dong Bai 2 Jia-Qi Liu 1 Zhao Zheng 1 Hao Guan 1 Qin Zhou 1 Lin-Lin Su 1 Song-Tao Xie 1 Yun-Chuan Wang 1 Jun Li 1 Na Li 1 Yi-Jie Zhang 1 Hong-Tao Wang 1 Da-Hai Hu 1
Affiliations

Affiliations

  • 1 Department of Burns and Cutaneous Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • 2 Department of Hematology, Urumqi General Hospital of Chinese People's Liberation Army, Urumqi 830000, China.
Abstract

Recent MicroRNA expression profiling studies have documented an up-regulation of miR-146a in several angiogenesis models. However, the underlying molecular mechanism of miR-146a in the angiogenic activity of endothelial cells has not been clearly elucidated. The present study was aimed to evaluate whether miR-146a promotes angiogenesis in HUVECs by increasing FGFBP1 expression via directly targeting CREB3L1. miR-146a was over expressed in HUVECs via lentiviral-miR-146a. Expression profiling analysis found miR-146a over expression resulted in up-regulation of angiogenesis and cytokine activity associated genes including FGF2. Further a combination of bioinformatics and experimental analyses demonstrated the CREB3L1 as a bona fide functional target of miR-146a during angiogenesis. Moreover, CREB3L1 inhibited luciferase expression from FGFBP1 promoter containing only CRE elements. Furthermore, CREB3L1 inhibited FGFBP1 expression by binding to two CRE-like sites located at approximately -1780-1777 and -868-865 bp relative to the FGFBP1 transcription start site. Additionally, ectopic expression of CREB3L1 decreased miR-146a-induced FGF2 secretion. These findings indicate that the miR-146a-CREB3L1-FGFBP1 signaling axis plays an important role in the regulation of angiogenesis in HUVECs and provides a potential therapeutic target for anti-angiogenic therapeutics.

Figures
Products